MGC in bid to tap Russian medicine market

MGC Pharmaceuticals’ continued success in clinical trial tests on COVID-19 patients has seen the company take a significant step towards having its natural supplement “ArtemiC” registered as a medicine in Russia with the anti-inflammatory product emerging as a serious contender in the global race to find an effective and safe treatment for the virus.

Next Post

Vic man charged over threats to AFL player

Tue Aug 25 , 2020
Victoria Police have tracked down and charged a Frankston man who allegedly threatened Richmond AFL player Dylan Grimes and his family.